Report Highlights
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Report Includes
- 33 data tables and 111 additional tables
- Analysis of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances
- Facts and figures pertaining to R&D activity, technology issues, industry-specific challenges, and the impact of macroeconomic factors
- A look at the regulatory and pricing scenarios in the global market, with an emphasis on recent regulations in the U.S., Europe and Japan
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Patent activity and key granted and published patents
- Company profiles of major players within the industry, including Medtronic, Abbott, Johnson & Johnson, Siemens Healthineers AG, and F. Hoffmann-La Roche Ltd.
Report Scope
This research report provides an in-depth analysis of the global medical device market and its competitive landscape through 2023. The report covers key players, competitive intelligence, advanced technologies and company profiles. The analysis includes recent developments and product portfolios of major players, as well as market share analysis and ranking. The analysis of the regulatory landscape focuses on recent regulations in regions such as the U.S., Europe and Japan. BCC Research estimates market size data for 2023 (base year) and forecasts values for 2024 through the end of 2029. This report also examines growth trends, drivers, restraints and opportunities in the global medical device market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||||||||||||||||||||||||
| Forecast period considered | 2024-2029 | ||||||||||||||||||||||||||||||||
| Base year market size | $739.6 billion | ||||||||||||||||||||||||||||||||
| Market size forecast | $1.3 trillion | ||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 9.8% for the forecast period of 2024-2029 | ||||||||||||||||||||||||||||||||
| Units considered | $ Billions | ||||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
This report discusses exhaustive coverage of the medical device industry and its competitive landscape in terms of major player market ranking and top medical devices. Company profiles of the top fifty medical device companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well-researched and analyzed in this report. The study includes tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the medical device industry and the factors that will affect the industry in the coming years.
Report Includes
- 72 data tables and 113 additional tables
- An up-to-date assessment of the global medical devices market and industry competitive landscape featuring top 50 medical device manufacturers
- Estimation of the actual market size and revenue forecast for global medical devices market in USD million values, with analyses and growth forecasts through 2021
- Discussion of the major market potential and opportunities in medical devices industry, along with a detailed analysis of the competitive environment, regulatory scenario, and recent technological advancements
- In-depth information on increasing investments on research and development (R&D) activities, key technology issues, industry specific challenges, and COVID-19 implications on the progress of medical devices marketplace
- Review of the regulatory landscape for global medical devices manufacturers with emphasis on recent regulations in regions such as the U.S., Europe, and Japan
- Market share analysis of leading medical device manufacturers, their research priorities, global rankings, manufacturers mapping by therapeutic area, and market development strategies
- Company profiles of the leading global corporations in the medical devices industry, including Abbott, Bio-Rad Laboratories Inc., Danaher Corp., General Electric, Medtronic, Olympus Corp., Stryker Corp. and Terumo Corp.
Report Highlights
This report discusses the medical device industry and its competitive landscape in terms of major player market ranking and top medical devices. Company profiles of the top 50 medical device companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well-researched and analyzed in this report.
Report Includes
- 61 data tables and 110 additional tables
- Competitive landscape of the top 50 medical device manufacturers in the global medical devices market
- Analyses of the global market trends, with data corresponding to market size in dollar value terms, and revenue forecasts through 2019
- Assessment of manufacturers ranking by R&D expenditures and annual growth, their market share analysis and key strategies adopted, and innovations taken place in medical devices marketplace
- Information pertaining to new product launches and approvals, mergers and acquisitions, alliances and joint ventures, and R&D efforts within the medical devices industry
- Review of patents and patent applications (numbers) filed on medical device technologies with breakdown of patent data by technology type, assignee country, and stakeholder company
- Discussion on the impact of COVID-19 pandemic on the medical devices industry with emphasis on key factors underlying the impact and significant takeaways
- Profile description of the major market players, including 3M, Abbott, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Danaher Corp., Roche, GE Healthcare, Johnson & Johnson and Siemens Healthcare AG
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Continuous Glucose Monitoring (CGM): Technologies and Global Markets
The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More